To better your understanding of non-clinical career options and/or facilitate your physician career change, today we introduce you to Steven D. Targum, MD. Dr. Targum serves as Chief Medical Officer at BrainCells, Inc. (BCI), a biopharmaceutical company focused on the development of breakthrough small molecule therapeutics for diseases of the central nervous system (CNS).
He works with the scientific team to translate the BCI neurogenesis platform into clinical drug development strategies.
Presently, Dr. Targum is a consultant in psychiatry at the Massachusetts General Hospital (Boston) and lecturer at the Harvard Medical School. Previously, Dr. Targum was Professor of Psychiatry and Vice-Chair of the Department of Mental Health Sciences at Hahnemann University School of Medicine (Philadelphia) from 1989-1995.
Dr. Targum founded PharmaStar in 2001, a training and education company focused on CNS drug development, which was sold in October 2004. He also developed and operated a multi-site clinical trials program which he sold in 1996.
Dr. Targum consults widely to the pharmaceutical industry regarding the design and implementation of clinical trials for new psychotropic drugs and the progression of drug development from approval to launch. He has published over 100 scientific articles in the areas of psychopharmacology, psychobiology, and clinical trials methodology, lectured extensively, and conducted over 200 clinical drug trials for numerous pharmaceutical sponsors.
For more information about Dr. Targum or BCI, please visit the company website.
